February 24, 2021 by Chain Drug Review
Chris Krese, Christie Boutte, Kathleen Jaeger, NACDS, Steve Anderson
Leading Headlines, Pharmacy

ARLINGTON, Va. – Focused on delivering value to the membership, the National Association of Chain Drug Stores (NACDS) has announced three moves to advance a pro-patient and pro-pharmacy agenda. NACDS is fully integrating its federal legislative, grassroots, political, and strategic communications functions. The Association also is focused on emphasizing a highly collaborative approach to strategic
February 15, 2021 by Chain Drug Review
Comprehensive Addiction and Recovery Act, NACDS, opioid abuse crisis, Steve Anderson
Issue 02-15-2021, News

ARLINGTON, Va. — The Drug Enforcement Administration’s (DEA’s) rulemaking that implements a 2016 law allowing for the partial filling of Schedule II controlled substances is a necessary step to help address the opioid abuse epidemic, yet changes are recommended to ensure success, according to the National Association of Chain Drug Stores. NACDS submitted comments this
February 8, 2021 by Chain Drug Review
Craig Norman, NACDS Regional Chain Conference, Rick Keyes, Steve Anderson
Featured Articles, Leading Headlines, News, Pharmacy

ARLINGTON, Va. — Regional pharmacy operators are playing an outsize role in “restoring hope for individuals in communities throughout the country,” National Association of Chain Drug Stores president and CEO Steve Anderson said today. “This industry, and this profession, has said for decades that pharmacies can do even more as health care destinations in enhancing
February 8, 2021 by Jeffrey Woldt
Biden administration, Chain Drug Review's Video Forum, NACDS, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy, Videos

With the Biden administration and the 117th Congress in place, we asked Steve Anderson, president and chief executive officer of the National Association of Chain Drug Stores, to share his thoughts about the current state of the nation’s government and politics, and what it means for retail pharmacy. Implications of last month’s riot on
January 4, 2021 by Steven Anderson
NACDS, Steve Anderson
Issue 01-04-2021, Pharmacy

You may have heard this one-liner popularized in 2020: “In 2015, everyone who answered the standard question ‘where do you see yourself in five years?’ got it wrong.” Given that few people in 2015 would have foreseen themselves five years later in a mask, in quarantine and confronting COVID-19’s many challenges, that comment describes well
August 6, 2020 by Chain Drug Review
Dr. Peter Cressy, George Washington Leadership Institute, NACDS, National Association of Chain Drug Stores, Steve Anderson
Leading Headlines, Videos

Steve Anderson, president and CEO of the National Association of Chain Drug Stores, and Dr. Peter Cressy, Director of Executive Programs at the George Washington Leadership Institute, have a conversation about the challenges facing associations and how leaders of today can learn from leaders of the past.
January 20, 2020 by Jeffrey Woldt
Anti-Kickback Statute, NACDS, Steve Anderson
Issue 01-20-2020, Opinion

The National Association of Chain Drug Stores has opened a new front in the battle to maximize the impact of pharmacy care on the well-being of patients and the efficient operation of the health care system. In an extensive set of comments sent to Department of Health and Human Services’ Office of Inspector General by
November 14, 2019 by Chain Drug Review
NACDS, Steve Anderson, Substance use disorder (SUD) treatment
Featured Articles, Leading Headlines, Pharmacy

ARLINGTON, Va.– Substance use disorder (SUD) treatment could benefit from pharmacists’ accessibility and expertise, the National Association of Chain Drug Stores (NACDS) wrote in detailed letters to 15 Medicaid program directors. NACDS also called for action on policy recommendations designed to help prevent opioid abuse and addiction, while caring for those in pain. NACDS made
February 18, 2019 by Chain Drug Review
2019 NACDS Regional Chain Conference, Mark Panzer, Rebecca Buble, Steve Anderson
Issue 02-18-2019, News

PALM BEACH, Fla. — The National Association of Chain Drug Stores’ campaign-style approach to the issues crucial for pharmacy value and viability dominated this month’s opening session of the 2019 NACDS Regional Chain Conference. NACDS’ top-priority issue of direct and indirect remuneration (DIR) fee reform headlined the discussion of the association’s “Access Agenda” — which
February 18, 2019 by Jeffrey Woldt
2019 NACDS Regional Chain Conference, DIR fees, Mark Panzer, Medicare Part D, NACDS, Steve Anderson
Issue 02-18-2019, Opinion

The National Association of Chain Drug Stores was at the top of its game during the Regional Chain Conference in Palm Beach, Fla., earlier this month. Often overshadowed by the association’s larger events, this hidden gem provides attendees with an initial look at the objectives that NACDS and its members will pursue during the course
January 31, 2019 by Chain Drug Review
NACDS, pharmacists, pharmacy, Steve Anderson
Leading Headlines

ARLINGTON, Va. – The National Association of Chain Drug Stores has responded to “The Unsung Role of the Pharmacist in Patient Health,” a New York Times article published on Jan. 28 that emphasizes the increasingly important role of pharmacists in health care delivery. NACDS president and CEO Steve Anderson wrote, “This column validates further the competence,
January 10, 2019 by Steve Anderson
NACDS, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy

Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. In health policy, 2018 and 2019 could look a lot alike. In October, the National Association of Chain Drug Stores was invited to the White House for two bill-signing ceremonies in as many weeks: one for legislation related to drug
September 26, 2018 by Chain Drug Review
gag clauses, Know the Lowest Price Act (S. 2553), NACDS, Patient Right to Know Prices Act (S. 2554), Steve Anderson, U.S. House of Representatives
Featured Articles, Leading Headlines, Pharmacy

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) lauded Congressional leaders for their efforts to empower pharmacists help patients reduce out-of-pocket drug costs. The U.S. House of Representatives approved the Senate-passed versions of the Patient Right to Know Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), thus
September 19, 2018 by Chain Drug Review
National Association of Chain Drug Stores (NACDS, Patient Right to Know Prices Act (S. 2554), save money on prescription drugs by ending so-called “gag clauses”, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) praised the U.S. Senate’s passage last evening of the Patient Right to Know Prices Act (S. 2554). The bill would help patients in private plans save money on prescription drugs by ending so-called “gag clauses” that prevent pharmacists from telling patients they could save